AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Apriglim MF 3mg/1000mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Aprica Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (3mg) + Metformin (1000mg)

Overview Apriglim MF 3mg/1000mg Tablet ER

Glimepiride/Metformin extended-release tablets (3mg/1000mg) are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your glycemic control. Continuous use is crucial, even with well-managed blood sugar, as abrupt cessation can elevate glucose levels, potentially causing kidney impairment, vision problems, neuropathy, and limb complications. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are integral to diabetes control. Hypoglycemia (low blood sugar) is the most prevalent adverse effect, manifesting as sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are vital preventative measures. Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Uses of Apriglim MF 3mg/1000mg Tablet ER

Managing type 2 diabetes

Major Benefits of Apriglim MF 3mg/1000mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Apriglim MF 3mg/1000mg Extended-Release Tablets. Ingest the tablets whole; do not chew, crush, or divide them. Administer this medication with a meal.

Common Side effects of Apriglim MF 3mg/1000mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Apriglim MF 3mg/1000mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Apriglim MF 3mg/1000mg Extended-Release Tablets. Ingest the tablet whole; do not damage it by chewing, crushing, or breaking. Administer this medication with food.

How Apriglim MF 3mg/1000mg Tablet ER works:

Apriglim MF 3mg/1000mg Extended-Release tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Apriglim MF 3mg/1000mg Tablet ER with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Apriglim MF 3mg/1000mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Apriglim MF 3mg/1000mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Exercise caution when prescribing Apriglim MF 3mg/1000mg Tablet ER to individuals with impaired renal function; dosage modification may be necessary. Consult a physician before administering. This medication is contraindicated in patients exhibiting severe kidney disease. Close monitoring of kidney function is recommended throughout the treatment course.

LiverLiverCAUTION

Patients with liver impairment should use Apriglim MF 3mg/1000mg Extended-Release tablets cautiously. Dosage modification of Apriglim MF 3mg/1000mg Extended-Release tablets may be necessary. Medical advice is recommended. Initiation of Apriglim MF 3mg/1000mg Extended-Release tablets typically begins with a low dose for individuals with mild to moderate hepatic dysfunction; however, its use is contraindicated in those with severe hepatic impairment.

What if you forget to take Apriglim MF 3mg/1000mg Tablet ER :

Should you forget a dose of Apriglim MF 3mg/1000mg Extended-Release Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Apriglim MF 3mg/1000mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes medication

FAQs on Apriglim MF 3mg/1000mg Tablet ER

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Apriglim MF 3mg/1000mg Tablet ER can cause lactic acidosis, a serious, potentially fatal build-up of lactic acid in the blood (also known as MALA, or Metformin-associated lactic acidosis). This rare but dangerous side effect is more likely in patients with kidney disease, older adults, and heavy alcohol users. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, stop taking Apriglim MF and seek immediate medical attention.
Apriglim MF 3mg/1000mg Extended-Release tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Apriglim MF 3mg/1000mg Tablet ER may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Apriglim MF 3mg/1000mg Tablet ER use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, neurological issues such as numbness, tingling in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Apriglim MF 3mg/1000mg ER tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Apriglim MF 3mg/1000mg ER tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Apriglim MF 3mg/1000mg Ta...
69
MRP 80
13% off